Washington, October 7 : Metabolic syndrome can significantly increase the risk of colorectal cancer, according to a new study.
Dr. Donald Garrow and Dr. Mark Delegge of the Medical University of South Carolina in Charleston say that metabolic syndrome patients were found to have a 75 percent higher risk of colorectal cancer, compared to those without metabolic syndrome, during the study.
While making a presentation at the 73rd Annual Scientific Meeting of the American College of Gastroenterology, the researchers revealed that they analysed data of patients who reported a history of metabolic syndrome and colorectal cancer from the National Health Interview Survey (NHIS), a comprehensive nationally representative study conducted each year by the National Center for Health Statistics.
Metabolic syndrome was defined as having a combination of three common chronic medical conditions: hypertension, diabetes and elevated cholesterol.
The risk of colorectal cancer among patients with metabolic syndrome was determined by multivariate logistic regression analysis, controlling for age, race, gender, obesity, smoking and alcohol use.
"Since individuals with the metabolic syndrome have a significantly higher lifetime risk of colorectal cancer, they should closely adhere to published guidelines for colorectal cancer screening," said Dr. Garrow.
The researchers suggested that losing weight, eating a healthy diet, and exercising routinely can help to reduce your risk of metabolic syndrome.